Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Glezer Eli N.. Officer active across 1 company, notably Singular Genomics Systems, Inc.. In total, 15 disclosures have been logged. Breakdown: 3 buys · 0 sell. Total volume traded: €302k. Activity tracked since 12 December 2022. The latest transaction was disclosed on 16 November 2023 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Glezer Eli N.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
50,000 shares@ US$2.0031.5% of flowCommon StockSEC:0001209191-22-061046:0
Canonical exit: 12 Mar 2023 (T+90)
15 of 15 declarations
About Glezer Eli N.
Glezer Eli N. is a declarant linked to Singular Genomics Systems, Inc., where the listed role is Chief Scientific Officer. Across 15 filings, the sampled filings run from 2022-12-13 to 2025-02-25, with EUR 302113 in buys and EUR 0 in sells, and the modal transaction nature is Levée d'options.